Carvedilol significantly reduced mortality from cardiovascular causes and Study Rundown: The CAPRICORN trial demonstrated that. London, UK – Results of the CAPRICORN trial confirm the benefit of the beta blocker carvedilol (Coreg® – GlaxoSmithKline) in reducing. Description: The CArvedilol Post-infaRct survIval COntRolled evaluatioN ( CAPRICORN) trial was a randomized, placebo-controlled trial.
|Published (Last):||11 May 2009|
|PDF File Size:||17.76 Mb|
|ePub File Size:||16.44 Mb|
|Price:||Free* [*Free Regsitration Required]|
Possible indications and treatment schemes for carvedilol in patients with acute MI are discussed. A double-blind randomized trial. Article Tools How to cite item.
METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
Data of the studies comparing influence of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Email this article Login required.
Effects on mortality during five years after early intervention with metoprolol in suspected acute myocardial infarction. Keywords acute coronary syndrome ambulatory blood pressure monitoring amlodipine apixaban arterial hypertension atherosclerosis atrial fibrillation beta-blockers cardiovascular diseases chronic heart failure hypertension ischemic heart disease lisinopril metabolic syndrome myocardial infarction obesity risk factors rivaroxaban statins stroke warfarin.
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: Generally, the patients recruited to these trials were at low risk: N Engl J Med ; JAMA ; The Lopressor Intervention Trial: Metoprolol in acute myocardial infarction. Register with this site Forgot your password?
Pharma commercial intelligence, news & analysis | Evaluate
Van de Werf F. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Last changes in guidelines regarding beta-blockers prescription to patients with MI are presented.
Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: MoscowRussia Petroverigsky per. Ccarvedilol was by intention to treat. Editor in chief Boytsov S. The beneficial effects of beta-blockers on long-term outcome after acute myocardial infarction were shown before the introduction of thrombolysis and angiotensin-converting-enzyme ACE inhibitors.
Lopressor Intervention Trial Research Group. Clin Res Cardiol ;95 1: Effect on mortality of metoprolol in acute myocardial infarction.
User Username Password Remember me Not a user? Am Heart J ; 4: J Am Coll Cardiol ;51 2: Acta Med Scand ; 3: J Am Coll Cardiol ;49 9: After myocardial infarction carvedilol improves insulin resistance compared to metoprolol. Study medication was progressively increased to a maximum of 25 mg twice daily during the next weeks, and patients were followed up until the requisite number of primary endpoints had occurred. About the Authors B. Pacing Clin Electrophysiol ;28 Suppl 1: Effect of timing, dosage, and infarct location.
Am J Cardiol ;56 Basic Clin Pharmacol Toxicol ; 2: Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention — the PASSAT Study.